v3.26.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities    
Net loss for the period $ (45,218,074) $ (4,481,751)
Item not affecting cash    
Amortization and depreciation 2,181,760 281,749
Bad debts 368,228 0
Amortization of loan initiation fees 373,888 82,891
Finance expenses 1,764,835 480,692
Loan derivative finance expense 18,112,444 712,652
Stock-based compensation 2,888,503 521,547
Stock issued for services 319,982 817,772
Loss on the sale of assets 14,122 0
Changes in non-cash working capital    
Accounts receivable (976,977) 80,361
Inventory of Drone Components (2,842,794) 0
Other current assets (883,380) (55,335)
Accounts payable and accrued liabilities (2,520,991) 167,604
Contract Liabilities (289,593) (7,784)
Change in dues from affiliate (8,753,621) (8,434,818)
Cash Used in Operating Activities (35,461,668) (9,834,420)
Investing Activities    
Purchase of PPE (7,969,908) (398,475)
Proceeds from sale of assets 4,630 0
Note receivable - principal 0 23,975
Marketable securities (9,233,029) 0
Acquisition costs (7,604,441) 20,882
Product development costs (2,245,754) (1,050,450)
Long-term Assets (Capital Advances) (2,266,674) (522,176)
Cash Used in Investing Activities (29,315,176) (1,926,244)
Financing activities    
Loans Borrowed 65,308,316 10,784,633
Lease payments (333,180) (30,835)
Warrants exercised 3,321,290  
Proceeds from the issuance of debentures 0 402,773
Proceeds from stock sale 0 4,133,402
Repayment of loans (834,384) (407,799)
Cash Provided by Financing Activities 67,462,042 14,882,174
Effect of foreign exchange (458,907) 631,381
Change in cash 2,226,291 3,752,891
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance 3,754,075 1,184
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance 5,980,366 3,754,075
Cash and Cash Equivalents Consist of    
Cash in bank $ 5,980,366 $ 3,754,075